SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

Validogen is launching next-generation synthetic methanol-free promoters, which may lead to “substantially increased productivities.” ...

Boehringer Ingelheim has acquired an exclusive license for a preclinical, small molecule program from Sitryx Therapeutics.

Asahi Kasei has agreed to acquire all issued shares of Aicuris Anti-infective Cures AG, a German-based biopharmaceutical company.

Expands Quotient's capabilities for handling and manufacturing highly potent API (HPAPI) drug molecules and products.

Alkermes, a global biopharmaceutical company headquartered in Ireland, is transitioning to a new Chief Executive Officer (CEO ...

Nexus Precision Health, a precision medicine technology company, has acquired Leal Health, an AI-powered patient ...

Asahi Kasei Pharma has entered an exclusive global license agreement with Alchemedicine covering novel lead compounds for a ...

The FDA has granted full approval to Pfizer Inc.’s Braftovi when used with Eli Lilly’s Erbitux (cetuximab) and fluorouracil‑based chemotherapy for adults with metastatic colorectal cancer carrying a ...

Brainlab and Precision NeuroMed have a new strategic partnership for an artificial intelligence (AI)-enabled treatment planning platform.

Avid Bioservices Inc., a dedicated biologics CDMO, has opened its new Early Phase Center of Excellence, a 78,000 square foot ...

How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.